Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Forte Biosciences, Inc. (FBRX) Other Working Capital Changes (2016 - 2020)

Forte Biosciences (FBRX) has disclosed Other Working Capital Changes for 5 consecutive years, with -$59000.0 as the latest value for Q4 2020.

  • On a quarterly basis, Other Working Capital Changes fell 278.79% to -$59000.0 in Q4 2020 year-over-year; TTM through Dec 2020 was $263000.0, a 8866.67% increase, with the full-year FY2024 number at $1.4 million, up 61.72% from a year prior.
  • Other Working Capital Changes was -$59000.0 for Q4 2020 at Forte Biosciences, down from $1.7 million in the prior quarter.
  • In the past five years, Other Working Capital Changes ranged from a high of $3.3 million in Q3 2018 to a low of -$3.6 million in Q4 2018.
  • A 5-year average of $20400.0 and a median of $26500.0 in 2017 define the central range for Other Working Capital Changes.
  • Peak YoY movement for Other Working Capital Changes: crashed 17960.0% in 2018, then skyrocketed 10768.75% in 2020.
  • Forte Biosciences' Other Working Capital Changes stood at -$425000.0 in 2016, then soared by 104.71% to $20000.0 in 2017, then plummeted by 17960.0% to -$3.6 million in 2018, then soared by 100.92% to $33000.0 in 2019, then plummeted by 278.79% to -$59000.0 in 2020.
  • Per Business Quant, the three most recent readings for FBRX's Other Working Capital Changes are -$59000.0 (Q4 2020), $1.7 million (Q3 2020), and -$1.7 million (Q2 2020).